Answers are grounded in this paper and cite their sources.
Structural iron (Fe3+)-bearing clay minerals, when they are reduced, can mediate electron transfer through the Fe3+/Fe2+ coupling reaction and transform hexavalent chromium (Cr6+) into less toxic Cr3+, which in turn can be removed from the solution by the clay minerals. Two types of clay minerals with different structural iron (Fe3+) contents, montmorillonite (2.3 wt%) and nontronite (22.3 wt%), were subjected to reaction with 50 mM dithionite at pH 9 for 48 hours, resulting in Fe2+ bearing clay minerals, with measured Fe2+ ratios of 0.68 and 0.49, respectively. Subsequently, the Fe2+ bearing clay minerals were reacted with Cr6+ solution with varying pH ranging from 2.5 to 11 in an anaerobic chamber. Results show that the reduction of Cr6+ was observed at all pH conditions, consistent with the stoichiometric ratios with structural iron (Cr6+:Fe2+/1:3). At pH 7 and below, over 99% of the structural iron (Fe2+) participated in the reduction reaction. At pH 9 and 11, however, the reaction exhibited a shortfall, with approximately 7-27% and 20-32% of unutilized structural iron remaining in montmorillonite and nontronite, respectively. According to the Visual MINTEQ model and DTPA extraction experiments conducted on solids obtained, Cr3+ is immobilized through sorption onto the clay mineral surface at pH 4.5 and below, and through precipitation and deposition on the clay mineral at pH 7 and above. SEM-EDS analysis, the presence of precipitated Cr at pH 7 and above was identified, and XPS analysis confirmed its precipitation in the form of Cr(OH)3.
No takes yet. Share an insight, caveat, or question.
Moon et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: